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Techniques forAssessingTeratogenic Effects:
Epidemiology
byJ. William Flynt, Jr.*
Epidemiologic studies of malformations can aid in the understanding of human teratogenesis.
Employing a variety ofapproaches epidemiology can develop or test hypotheses concerning possi-
ble causes or through surveillance provide data useful for a variety of purposes. Drawing heavily
upon ourexperiences at the Center for Disease Control, this paperreviews some concepts and uses
ofepidemiology in studies ofhuman teratogenesis.
Epidemiology is the study of the distribution
and determinants of disease among populations.
It is the study ofthe causes and manifestations of
disease and of their associations. This paper
focuses on the use of epidemiology to study
human structural malformations and their en-
vironmental determinants. Epidemiologic studies
of malformations may be classified as descriptive
or analytic. In descriptive studies, malformation
cases are characterized according to frequency,
race, sex, or other variables related to their oc-
currence; in analytic studies their associations
with possible environmental determinants are
defined and tested. Another part of the
epidemiology of malformations is surveillance,
the routine collection, analysis, and reporting of
data.
Some concepts should be kept in mind when
considering epidemiologic studies of malfor-
mations and teratogenesis. First, structural
malformations are only one of several pregnancy
outcomes influenced by environmental deter-
minants. Others include spontaneous abortion,
fetal and infant death, low birth weight, mental
retardation, deafness, and blindness. Limiting at-
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tention to malformations only excludes other ef-
fects of the environment on the fetus. For prac-
tical reasons, studies are generally restricted to
one outcome, but the other disorders should be
kept in mind, particularly when the study design
allows consideration ofthem.
Second, unless there is evidence for grouping
malformations, each should be considered
separately, even those involving the same body
system. Patients with anencephaly-spina bifida
(ASB), for example, have alower proportion ofaf-
fected males, greater racial variation, and more
familial recurrence than patients with
hydrocephalus alone (1-4). Similarly, patients
with cleft lip with or without cleft palate differ
epidemiologically and, therefore, probably
etiologically from those with cleft palate only (5).
In fact, patients with cleft lip and palate plus
other malformations differ epidemiologically
from those with facial clefts only (6). Despite the
frequent need for larger numbers of cases to
study, the cases should not be combined without
regard for their possible epidemiologic or
etiologic differences.
Third, one malformation can have a variety of
causes, and one cause can result in a variety of
malformations. Rubella infection during pregnan-
cy, for instance, can cause congenital heart de-
fects, cataracts, mental retardation, and deafness
in affected infants. Conversely, congenital cata-
racts, while caused by the rubella virus, can also
December 1976 117occur with over 20 other conditions, including
Down's syndrome, a chromosomally determined
condition, and galactosemia, a genetically deter-
mined biochemical abnormality (7).
Last, many factors and teratogenic
mechanisms determine the number and type of
human malformations caused by exposure in
utero to an environmental teratogen. Discussion
of these factors and mechanisms is beyond the
scope of this presentation, but they have been
considered in some detail by Wilson (8).
Knowledge ofthese mechanisms must be brought
to bear on epidemiologic studies. For instance, an
important determinant of malformations is the
gestational age at which the fetus is exposed to
the teratogen. The now classic example is
thaliodomide, which produced a variety of struc-
tural abnormalities among infants exposed in
utero. Most typical were reduction deformities of
the limbs and anotia; other anomalies included
duodenal stenosis and atresia, heart anomalies,
facial hemangiomata, and anophthalmia or
microphthalmia (9, 10). Early in the studies of
thalidomide, investigators reported that at least
139 pregnant women had taken the drug without
its causing fetal malformations. Upon
establishing more precisely when the mother
took it, however, they defined the em-
bryosensitive period as 34-50 days after the first
day of the last menstrual period (11). Embryos
exposed during this period were malformed;
those exposed outside this sensitive period were
unaffected. In this instance, the fact of exposure
had to be further qualified by the time of ex-
posure. When this was done, the findings were
consistent with knowledge about the timing of
normal embryogenesis.
Descriptive Epidemiology
Descriptive epidemiology characterizes pa-
tients with malformations according to such vari-
ables as geographical differences, seasonal pat-
terns, socioeconomic and racial influences, and
maternal age effects. Such studies may identify
high or low incidence populations which can sug-
gest areas for further work. The vast majority of
epidemiologic studies in humans to date have
been descriptive.
ASB has been well described epidemiologically
because two circumstances have made these
defects especially well suited for study: affected
infants are easily recognized and reliably repor-
ted and cases occur with sufficient frequency that
adequate numbers can be assembled for study.
From these descriptive studies have come an
epidemiologic picture of ASB which suggests in
part an environmental etiology. Pronounced
geographic differences exist between countries
and even within the same country. In Ireland, for
instance, over 1% of newborns are affected with
ASB, while in Great Britain a two- to threefold
increase in rates occurs in a progression from
southeast to northwest (3, 12). In the United
States, the ASB incidence declines from east to
west with the rates of 1.0 per thousand in the
South being twice that in the West (13). Other
findings also suggestive of environmental factors
include an inverse relationship between ASB in-
cidence and socioeconomic status (14, 15) and in-
cidence changes of epidemic proportions over
time (16, 17).
Descriptive studies of malformations in the
United States have generally drawn upon three
data sources: vital records (birth, death, and fetal
death certificates), available hospital records,
and special clinical surveys often employing stan-
dard infant examinations. Each source has ad-
vantages and disadvantages in terms ofreporting
completeness, uniformity and reliability of
diagnosis, and ease with which the data are ob-
tained. Vital records yield rates of 1% to 1.5% for
total malformed infants, hospital records yield
rates of 2.5% (18-20), and intensive clinical sur-
veys yield rates ranging from 5% to 15% (21-23).
These ranges reflect the composite effect of
several variables, including the completeness of
recognition and recording of malformations, the
infant's age at diagnosis, and the definitions used
to distinguish malformations, variants, and states
of normalcy. The intensive clinical studies
provide the highest rates because they insure
that every newborn receives a standard
examination with special attention to such
relatively inconspicuous conditions as ear shape,
the configuration of fingers or toes, and the
existence of more trivial birth marks. Of the
other two sources, vital records are the most
deficient (20), yet they are still quite suitable for
some uses. For example, studies of seasonality or
the effects of maternal age and parity upon the
occurrence of some malformations can be done
with vitalrecord data.
Another determinant of malformation case
rates is the age at which malformations are
recognized and still reported (21, 24, 25). Internal
anomalies of the cardiovascular, renal, and
gastrointestinal systems in particular may not be
evident until some weeks, months, or even years
after birth. Therefore, rates will be higher from
Environmental Health Perspectivesdata sources which provide for ascertainment of
cases into later life.
Descriptive studies require sizeable case num-
bers and knowledge of the characteristics of the
general population from which the cases are
drawn, For this reason, they often use data
available from the Bureau of the Census or from
state vital records departments. These
populations generally conincide with county,
multicounty, or state boundaries and hence are
geographically (or population) based.
The use of a geographic base can pose problems
of case ascertainment. Identifying and register-
ing cases over a large geographic area requires
the cooperation of many hospitals and sometimes
other facilities where malformed infants are seen.
The involvement of a number and variety of data
sources precludes an intensive clinical examina-
tion of each infant. Therefore, one must develop
some mechanism for obtaining case reports which
combines hospital and vital record reporting,
realizing that there will be some loss in reporting
completeness.
One example of such a community-based sur-
veillance program is the Metropolitan Atlanta
Congenital Defects Program (26). The Program is
conducted jointly by the Center for Disease Con-
trol (CDC), Emory University School ofMedicine,
and the Georgia Mental Health Institute and
covers a five-county area with approximately
25,000 births annually. Infants with malfor-
mations are identified by staff members who
regularly visit each of the 21 Atlanta area
hospitals with obstetrical or pediatric services.
The staff register all infants with structural,
chromosomal, or biochemical abnormalities
diagnosed up to age 1 year. The most completely
reported abnormalities are those evident in the
newborn period. Data from these case-finding ef-
forts are supplemented by vital records in-
formation furnished by the Georgia Department
of Human Resources and by laboratory records of
chromosomal abnormalities.
Analytic Epidemiology
From descriptive studies, laboratory in-
vestigations, clinical reports and other sources,
then, come leads about possible human
teratogens. These leads generally result in
hypothesis testing with analytic studies. The
data available from the Atlanta program, for
example, have been used for analytic studies of
drugs and other environmental teratogens. In
1973, on the heels of a reported association be-
tween parental use of spray adhesive compounds,
chromosomal damage, and congenital malfor-
mations, we compared time trends for the rate of
malformations with the sales of the suspected
teratogen (Fig. 1) (27). In the face ofa marked in-
crease in sales no change occurred in the rates of
all malformations, infants- with multiple defects,
or any single malformation. To determine the ex-
tent to which pregnant women might have been
exposed to the compounds, 173 postpartum
women in five Atlanta hospitals were in-
terviewed abouttheir exposure to spray adhesive
compounds: nine (4.6%) reported having used
them at some time. While the lack ofchange in in-
cidence is evidence against substantial
teratogenesis, a small effect could have been
present and not detected by this method.
However, by using these same data, an estimate
also can be made of the maximum teratogenic
risks which the compounds pose. In this case, the
proportion of women at teratogenic risk was the
proportion of women exposed to spray adhesives
who had malformed babies. The rarer the defect,
the smaller the risk that might be detected. From
the interview data it is estimated that some 5%
(1400) of the 28,000 Atlanta women delivering
babies in 1973 were potentially exposed. If these
compounds affected, for example, 2% of the 1400
pregnancies, there would be 28 "extra" cases
from exposure. This would appear as a twofold
increase over the usual malformation rate of 1 per
1000 or less. (Roughly 95% of the 130 different
malformations coded in Atlanta occur at this
frequency or less.) In the unlikely event that
spray adhesive compounds caused an increase in
all malformations, a 100/ risk would be detec-
table. In this instance there would be an added
140 cases (10% of 1400) tothe 700 which occur an-
nually. For more intermediate case rates, the
teratogenic risks would be between 2% and 10%.
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FIGURE 1. Trends in birth defect incidence and spray adhesive
sales, metropolitan Atlanta, 1969-1973.
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119Two other types of analytic studies are the
case-control and cohort studies. The case-control
study examines a group ofcases with 1 or more of
the same malformation(s) and a group of suitable
controls, comparing their frequencies ofexposure
to an environmental agent or the presence of
some other determinant. Greater frequency of
exposure among the case group may suggest a
causal association with the malformation under
study. Since the data on exposure are collected
after the malformation has been diagnosed, the
case-control study is in the temporal sense
retrospective.
Another phase of the Metropolitan Atlanta
Congenital Defects Program is the regular in-
terview ofmothers 3 months after the birth of an
infant with any of 12 selected malformations.
Mothers are questioned about their occupation
before and during pregnancy, their residence at
conception, any illnesses, and any drugs taken
during pregnancy. When the interviews began in
1970, Gal et al., also using a case-control study,
had reported an association between the use of
hormonal tests for pregnancy and the later birth
of infants with defects of the central nervous
system (28). As part of the Atlanta interview we
included a question about the hormonal pregnan-
cy test. Over a 3-yr period, 123 mothers ofinfants
with ASB and 310 mothers of infants with other
malformations, who served as controls, were in-
terviewed (Table 1). We chose these mothers as
controls because mothers of malformed infants
have been shown to recall more events during
pregnancy than mothers of normal infants (29).
We found no significant differences in frequency
of use ofthe hormonal pregnancy test (30).
The second type of analytic study is the cohort
approach. These studies begin with the fact of ex-
posure, for example, a group of pregnant women
exposed to an environmental teratogen. These
women and a comparison group, preferably
similar in all respects except exposure, are then
followed prospectively from exposure to out-
come. Alternatively, the exposed and unexposed
cohorts are analyzed retrospectively after
pregnancy has ended. So long as the presence or
absence of exposure is defined independent of
any knowledge of pregnancy outcome, the
"retrospective" nature of such a study need not
be reason for skipticism. In fact, this latter ap-
proach can be preferable since there need not be
provisions for long-term observation of the ex-
posed and non-exposed cohorts.
One notable advantage of cohort studies of
teratogenesis is that a variety of poor pregnancy
Table 1. Frequencyofuse ofthehormonal-pregnancy test
among mothers ofmalformed infants bytype ofmalformation
(metropolitan Atlanta,Georgia, 1970-73)
No. Positive
ofre-
Type ofmalformation sponses No. %
Total infants 433 46 10.6
Total neural-tube defects 123 10 8.1
Anencephaly alone 36 2 5.6
Anencephaly and spina 5 0 0.0
bifida
Spina bifida alone 78 8 10.3
Encephalocele 4 0 0.0
Cleftlip with or without cleft 71 8 11.3
palate
Cleftpalate alone 38 5 13.2
Down's syndrome 62 6 9.7
Other chromosomal 10 0 0.0
abnormalities
Esophageal atresia 11 3 27.3
Intestinal atresia 38 4 10.5
Omphalocele 34 4 11.8
Diaphragmatic hernia 10 1 10.0
Limb-reduction deformities 20 3 15.0
Syndromes (excludingDown's) 13 1 7.7
Infants withmultiple malforma- 70 11 15.7
tions
outcomes can be sought among the exposed
population. Providing the exposed women are
followed from early in pregnancy, the range of ef-
fects upon pregnancy, including abortion,
stillborn infants, and malformations can be deter-
mined. Continued follow-up of infants exposed in
utero might determine further effects such as
mental retardation, learning disabilities, deaf-
ness, or blindness. The commonly overriding
disadvantage of cohort studies is their expense.
The low frequency of most of these conditions
necessitates the study of large numbers of per-
sons. Acceptable statistical boundaries for such a
study might be a 95% certainty of detecting an
effect when present and a 5% risk that an ob-
served effect is falsely positive. Within these
limits, a cohort of approximately 700 exposed
pregnant women would be required to detect a
10-fold increase in a malformation which occurs
normally at a rate of 1 per 1000. Within the same
boundaries, detection of a twofold increase would
require enrollment of approximately 17,000 ex-
posed women.
'Surveillance
Surveillance is a third component of the
epidemiology of congenital malformations. Its
purposes include the provision of data for
Environmental Health Perspectivesdescriptive studies, the development of a
registry for case-control studies, and the
monitoring of malformation cases for changes
suggestive of environmental influences(31).
Monitoring and surveillance can be used in-
terchangeably so long as the term conveys a sen-
se of immediacy in the collection and analysis of
data. The importance ofmonitoring has been con-
sidered to be the early detection of thalidomide-
like epidemics. To date no such episodes have oc-
curred, to our knowledge, so the usefulness of
this approach has not yet been tested. Never-
theless, in the face of the countless new sub-
stances which current technology contributes to
the environment and whose teratogenic effects
upon humans are not known, malformation
monitoring must be considered prudent for the
foreseeable future.
While monitoring of malformation cases can
detect changes which might suggest en-
vironmental causes, it will not necessarily explain
the cause of the change. Vital to the monitoring
activity is the systematic comparison of the
current incidence of malformations with an ex-
pected value based on previous experience. Com-
parisons should provide for recognition of sudden
increases, gradually rising trends, and
geographic differences. Because of these many
and varied comparisons computers have come to
play an important role in monitoring.
The Metropolitan Atlanta Congenital Defects
Program has provided for the local monitoring of
malformation cases at monthly intervals since
1970. Although many increases have been noted,
most were transient, and to date no en-
vironmental cause for any of them has been
found. Four other programs, in Nebraska,
Washington, Upper New York State, and nor-
thern Florida, have also contributed to the
monitoring effort in this country. The Nebraska
and Florida programs use hospital records, while
the New York and Washington programs rely
upon vital records (31).
The first nationwide monitoring effort was
started at the Center for Disease Control in
December 1974 with the implementation of the
Birth Defects Monitoring Program (BDMP) (par-
tially funded by Interagency Agreement No. YO-
HD-31002) (13). This program was developed
jointly by CDC, the National Institute for Child
Health and Human Development, the National
Foundation-March of Dimes, and the Commission
on Professional and Hospital Activities (CPHA),
a health-data-processing organization located in
Ann Arbor, Michigan. Data used in the BDMP are
obtained from hospital discharge records of some
1,200 hospitals located throughout the country.
These BDMP hospitals are among those already
enrolled in CPHA's Professional Activity Study
(PAS), a computerized service for participating
hospitals.
The BDMP uses data on newborn discharges
already sent to CPHA by the PAS hospitals.
There are presently some 1 million births an-
nually in BDMP-PAS participating hospitals.
Because of the self-selection of these hospitals,
the data are not a random sample of U.S. births
nor are they geographically based. Nevertheless,
the BDMP represents the largest single source of
uniformly collected and coded data presently
available on malformations among newborns in
the United States. The percentage of live births
by census division in the BDMP varies from over
15% in the East and West South Central
Divisions to 51% in the East North Central
Division (Fig. 2). This variation reflects the self-
selection of hospitals which choose first and
primarily to participate in the PAS and, second,
in the BDMP. For a case with a malformation to
be used in the BDMP system, the defect must be
apparent at birth or during the newborn's nur-
sery stay, be noted by the attending physician,
and be recorded by the medical record depart-
ment staff on discharge abstracts routinely sent
to CPHA.
At CPHA a special data file is maintained for
all newborns discharged from BDMP hospitals
with any of some 200 different defects. Data
already available for 1970 through 1973 were en-
tered into this special file and are used as the
baseline rate for calculating the expected num-
bers of malformation cases. At quarterly in-
tervals, for each defect category the most recen-
tly observed number of cases is compared with
FIGURE 2. Percent of U.S. live births in the Birth Defects
Monitoring Program, by U.S. Census Division, January-
June 1975.
December 1976 121the expected. Comparisons are made for 3-, 6-,
and 12-month time periods and for geographic
areas ranging from individual county to the whole
United States. Whenever the observed number of
cases in any of these exceeds the expected num-
ber at the 0.01 level or greater, the defect and the
geographic area are listed on an exceptions
report by the computer. These lists along with
other data are then sent to CDC for analysis and
evaluation for possible environmental causes.
One of the more striking increases observed
early was a three- to four-fold increase in the in-
cidence of lung agenesis which occurred between
1973 and 1974 rather uniformly throughout the
United States (Fig. 3). Upon further inquiry it
was noted that a revision ofthe H-ICDA code (32)
instituted on January 1, 1974, had resulted in the
assignment of lung hypoplasia, a different but
related defect to the lung agenesis category.
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FIGURE 3. Annual incidence of lung agenesis and other lung
anomalies, U.S. 1970-1974.
Although in this instance a coding circumstance
caused an apparent increase, the episode shows
that the BDMP can detect these sudden changes.
This example also shows the need to know in-
timately the strengths, weaknesses, and in-
tricacies of one's data source. A more gradual,
but progressive increase in heart anomalies has
also been noted, exemplified by a steady rise sin-
ce 1970 in the rates for ventricular septal defect
(Fig. 4). Similar increases have been noted for
PDA, tetralogy of Fallot, and total heart
anomalies. We have no definite explanation for
these increases but believe them to be at-
tributable to better diagnosis and reporting.
During this same period there have been more
newborn intensive care nurseries established and
more aggressive care ofpremature and other sick
infants. Both would presumably result in greater
opportunity for detection and follow-up of cases
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FIGURE 4. Ventricular septal defect incidence rates, by census
region, U.S. 1970-1974.
with these conditions. However, a definitive ex-
planation can come only from special clinical
studies involving a large number of infants and
providing for special follow-up ofcases.
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